Branched endosomal disruptor (BEND) lipids mediate delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complex for hepatic gene editing and T cell engineering
Abstract Lipid nanoparticles (LNPs) are the preeminent non-viral drug delivery vehicle for mRNA-based therapies. Immense effort has been placed on optimizing the ionizable lipid (IL) structure, which contains an amine core conjugated to lipid tails, as small molecular adjustments can result in subst...
Saved in:
Main Authors: | Marshall S. Padilla, Kaitlin Mrksich, Yiming Wang, Rebecca M. Haley, Jacqueline J. Li, Emily L. Han, Rakan El-Mayta, Emily H. Kim, Sofia Dias, Ningqiang Gong, Sridatta V. Teerdhala, Xuexiang Han, Vivek Chowdhary, Lulu Xue, Zain Siddiqui, Hannah M. Yamagata, Dongyoon Kim, Il-Chul Yoon, James M. Wilson, Ravi Radhakrishnan, Michael J. Mitchell |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-55137-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EPA’s Endocrine Disruptor Screening Program (EDSP)
by: Frederick M. Fishel
Published: (2013-03-01) -
EPA's Endocrine Disruptor Screening Program (EDSP)
by: Frederick M. Fishel
Published: (2010-04-01) -
Editorial: Endocrine disruptors in molecular and structural endocrinology
by: Julianne M. Hall
Published: (2025-02-01) -
EPA's Endocrine Disruptor Screening Program (EDSP)
by: Frederick M. Fishel
Published: (2010-04-01) -
EPA’s Endocrine Disruptor Screening Program (EDSP)
by: Frederick M. Fishel
Published: (2013-03-01)